SCHEMBL23118730

SCHEMBL23118730

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5cc(-c6nc7ccccc7o6)ccc54)c3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.49
▸ SMN1; SMN2 Q16637 6/20 0.49
▸ ALDH1A1 P00352 6/20 0.49
▸ HPGD P15428 6/20 0.49
▸ HSD17B10 Q99714 5/20 0.49
▸ TP53 P04637 4/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ PKM P14618 1/20 0.49
▸ HPSE Q9Y251 3/20 0.46
▸ NPC1 O15118 7/20 0.43
▸ RAB9A P51151 5/20 0.42
▸ USP2 O75604 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ HCRTR1 O43613 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23118531 0.98 KDM4E (0.47) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL25459683 0.97 KDM4E (0.47) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL25459477 0.97 SMN1; SMN2 (0.47) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL23118822 0.97 KDM4E (0.48) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL23079976 0.96 SMN1; SMN2 (0.45) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL23079891 0.96 SMN1; SMN2 (0.45) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL23079839 0.95 SMN1; SMN2 (0.46) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL23079796 0.94 KDM4E (0.46) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL23080019 0.94 KDM4E (0.45) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10
SCHEMBL22843929 0.94 KDM4E (0.49) KDM4ESMN1; SMN2ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210078992-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078992-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, ODC1, PPOX KDM4E 2668/4885SMN1; SMN2 3763/4885ALDH1A1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback